CU20080124A7 - Enmascaramiento del sabor de polvos - Google Patents

Enmascaramiento del sabor de polvos

Info

Publication number
CU20080124A7
CU20080124A7 CUP2008000124A CU20080124A CU20080124A7 CU 20080124 A7 CU20080124 A7 CU 20080124A7 CU P2008000124 A CUP2008000124 A CU P2008000124A CU 20080124 A CU20080124 A CU 20080124A CU 20080124 A7 CU20080124 A7 CU 20080124A7
Authority
CU
Cuba
Prior art keywords
flavor mask
dust
dust flavor
mask
administration
Prior art date
Application number
CUP2008000124A
Other languages
English (en)
Other versions
CU23877B1 (es
Inventor
Rainer Bellinghausen
Daniel Rudhardt
Frank Ridder
Martin Steinbeck
Jesko Zank
Martin Weiss
Olaf Behrend
Stiphout Udo Van
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of CU20080124A7 publication Critical patent/CU20080124A7/es
Publication of CU23877B1 publication Critical patent/CU23877B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a nuevos polvos de sabor enmascarado para inhalación o administración oral, a un procedimiento sencillo para su preparación y a su uso para la administración de sustancias biológicamente activas.
CU20080124A 2005-12-24 2008-06-23 Enmascaramiento del sabor de polvos CU23877B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005062270A DE102005062270A1 (de) 2005-12-24 2005-12-24 Geschmacksmaskierung von Pulvern
PCT/EP2006/012284 WO2007073911A2 (de) 2005-12-24 2006-12-20 Geschmacksmaskierung von pulvern

Publications (2)

Publication Number Publication Date
CU20080124A7 true CU20080124A7 (es) 2010-08-30
CU23877B1 CU23877B1 (es) 2013-04-19

Family

ID=38042692

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20080124A CU23877B1 (es) 2005-12-24 2008-06-23 Enmascaramiento del sabor de polvos

Country Status (24)

Country Link
US (1) US20090269411A1 (es)
EP (1) EP1968555A2 (es)
JP (2) JP5275039B2 (es)
KR (2) KR20080081021A (es)
CN (1) CN101346133A (es)
AU (1) AU2006331009B2 (es)
BR (1) BRPI0620618A2 (es)
CA (1) CA2634481A1 (es)
CR (1) CR10112A (es)
CU (1) CU23877B1 (es)
DE (1) DE102005062270A1 (es)
EC (1) ECSP088577A (es)
GT (1) GT200800126A (es)
HN (1) HN2008000964A (es)
IL (1) IL192085A0 (es)
MA (1) MA30072B1 (es)
MY (1) MY149601A (es)
NZ (1) NZ569279A (es)
RU (1) RU2440103C2 (es)
SV (1) SV2009002971A (es)
TN (1) TNSN08284A1 (es)
UA (1) UA93072C2 (es)
WO (1) WO2007073911A2 (es)
ZA (1) ZA200805498B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
EP2050437A1 (en) * 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
US20110052699A1 (en) * 2008-02-13 2011-03-03 Adrian Funke Drug delivery system with stabilising effect
EP2249803A2 (en) * 2008-02-13 2010-11-17 Bayer Schering Pharma Aktiengesellschaft Estradiol-containing drug delivery system
CA2745456A1 (en) * 2008-12-05 2010-06-10 Bayer Animal Health Gmbh Extrudate having spicular active substances
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
UY32836A (es) * 2009-08-12 2011-03-31 Bayer Schering Pharma Ag Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato
CA2771358A1 (en) 2009-08-19 2011-02-24 Sascha General Drug delivery systems (wafer) for pediatric use
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
EP2611529B1 (en) 2010-09-03 2019-01-23 Bend Research, Inc. Spray-drying method
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
CN103619514B (zh) 2010-09-20 2016-09-28 Spi制药公司 微包囊方法和制品
EP2618924A1 (en) 2010-09-24 2013-07-31 Bend Research, Inc. High-temperature spray drying process and apparatus
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
US8993041B2 (en) * 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them
EP3212169B1 (en) 2014-10-31 2021-01-13 Bend Research, Inc. Process for forming active domains dispersed in a matrix
CN114993892B (zh) * 2019-05-13 2024-10-18 南京制药厂有限公司 吡喹酮粒度的光散射检测法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568559A (en) * 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
NZ507951A (en) * 1998-04-09 2002-12-20 Eurand Internat S Wettable microcapsules having hydrophobic polymer coated cores
FR2811913B1 (fr) * 2000-07-19 2003-09-19 Separex Sa Procede d'encapsulation sous forme de micro-capsules de fines particules solides
GB2405798A (en) * 2003-09-15 2005-03-16 Vectura Ltd Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device.

Also Published As

Publication number Publication date
CA2634481A1 (en) 2007-07-05
HN2008000964A (es) 2013-03-11
WO2007073911A3 (de) 2007-08-23
DE102005062270A1 (de) 2007-06-28
JP2013144695A (ja) 2013-07-25
AU2006331009A1 (en) 2007-07-05
NZ569279A (en) 2011-06-30
MY149601A (en) 2013-09-13
CU23877B1 (es) 2013-04-19
UA93072C2 (ru) 2011-01-10
KR20120006085A (ko) 2012-01-17
ZA200805498B (en) 2009-11-25
IL192085A0 (en) 2008-12-29
ECSP088577A (es) 2008-07-30
KR101245627B1 (ko) 2013-03-20
US20090269411A1 (en) 2009-10-29
BRPI0620618A2 (pt) 2011-11-16
EP1968555A2 (de) 2008-09-17
GT200800126A (es) 2010-06-25
CN101346133A (zh) 2009-01-14
WO2007073911A2 (de) 2007-07-05
AU2006331009B2 (en) 2012-10-04
TNSN08284A1 (en) 2009-10-30
CR10112A (es) 2009-01-07
RU2008130171A (ru) 2010-01-27
SV2009002971A (es) 2009-04-28
JP5275039B2 (ja) 2013-08-28
KR20080081021A (ko) 2008-09-05
JP2009521419A (ja) 2009-06-04
RU2440103C2 (ru) 2012-01-20
MA30072B1 (fr) 2008-12-01

Similar Documents

Publication Publication Date Title
ECSP088577A (es) Enmascaramiento del sabor de polvos
ATE556704T1 (de) Pulverinhalator-formulierungen
TW200716206A (en) Unitary pharmaceutical dosage form
UY31867A (es) Nuevas formulaciones farmacéuticas sólidas que comprenden bibw 2992
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
TW200716646A (en) (S)-N-methylnaltrexone
TW200738242A (en) Dihydropteridinones in the treatment of respiratory diseases
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
ATE505203T1 (de) Pharmazeutische kombination aus aliskiren und valsartan
MY145647A (en) (4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states)
EA201000677A1 (ru) Сухие порошкообразные композиции, содержащие производные аскорбиновой кислоты
IL197783A (en) Polycyclic compounds, preparations containing them and polycyclic compounds for use in the treatment of synthetic respiratory virus infections
WO2007025146A3 (en) Balsalazide formulations and manufacture and use thereof
WO2005041922A3 (en) Composition
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
PA8646301A1 (es) Inhibidores de la adenilato ciclasa soluble
MX2008013477A (es) Compuestos biciclicos de tetrahidropirrol.
BRPI0618370A2 (pt) formulação aerossol de medicamento, uso do mesmo e kit de inalação
CY1106013T1 (el) Ρινικη φαρμακευτικη συνθεση της πepιβεδιλης
GT200600244A (es) Inhibidores de la adenilato ciclasa soluble
IL191690A0 (en) Therapy of malignant neoplasias
CL2007000955A1 (es) Compuesto peptidico lantibiotico con actividad antimicrobiana obtenido de un cultivo de bacillus clausii; procedimiento de preparacion; composicion famrceutica que lo comprende; y uso del compuesto peptidico para tratar trastornos intestinales producto de enfermedades infecciosas.

Legal Events

Date Code Title Description
FG Grant of patent
FD Lapse (for not paying fees)